Saturday, 24 October 2026

Product News

Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel

Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets.

By Danielle Norton Updated 1 min read
Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets.

Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets.

Full prescribing information is available on request or alternatively please go to www.clonmel-health.ie. Medicinal product subject to medical prescription.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Related stories

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free